GI
RCEL icon

GAMMA Investing’s Avita Medical RCEL Stock Holding History

GAMMA Investing’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$785 Sell
190
-982
-84% -$4.24K ﹤0.01% 3924
2026
Q1 		$4.34K Buy
1,172
+1,105
+1,649% +$4.64K ﹤0.01% 3412
2025
Q4 		$231 Sell
67
-310
-82% -$1.24K ﹤0.01% 3988
2025
Q3 		$1.93K Buy
377
+85
+29% +$444 ﹤0.01% 3457
2025
Q2 		$1.54K Sell
292
-491
-63% -$3.57K ﹤0.01% 3454
2025
Q1 		$6.37K Sell
783
-25
-3% -$234 ﹤0.01% 2973
2024
Q4 		$10.3K Buy
808
+559
+224% +$6.59K ﹤0.01% 2601
2024
Q3 		$2.67K Buy
249
+175
+236% +$1.64K ﹤0.01% 2974
2024
Q2 		$586 Sell
74
-5
-6% -$48 ﹤0.01% 3178
2024
Q1 		$1.27K Buy
79
+62
+365% +$1K ﹤0.01% 2888
2023
Q4 		$285 Buy
+17
New +$195 ﹤0.01% 3077

Other funds holding RCEL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

GAMMA Investing's RCEL Position: Q2 2026 in Review

GAMMA Investing reduced its Avita Medical (RCEL) stake by 84% in Q2 2026, selling an estimated $4.24K and leaving 190 shares worth $785. The position accounts for ﹤0.01% of the portfolio, ranked #3924.

GAMMA Investing first reported a position in RCEL in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.3K in Q4 2024. 7 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • GAMMA Investing held 190 shares of Avita Medical worth $785 as of Q2 2026.
  • GAMMA Investing sold 982 Avita Medical shares in Q2 2026, an estimated $4.24K.
  • Avita Medical made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3924 holding.
  • GAMMA Investing first reported a position in Avita Medical in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Avita Medical position peaked at $10.3K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.